(A) Noncompetitive serial transplants were performed by transplanting 2 × 10⁵ sorted GFP⁺ cells from primary recipients of control or Gsk3-rnai transduced BM into lethally irradiated recipients (10 mice per group). Survival of secondary recipients receiving control or Gsk3-rnai BM is shown as a Kaplan-Meier plot. (B) Percent HSC-containing LSK fraction in control and Gsk3-rnai secondary recipients. (C) Absolute number of GFP⁺ LSK, LSK CD34^–Flk2^–, and LSK CD34⁺Flk2^– cells in control and Gsk3-rnai secondary recipients. (D) Representative FCM data, presented as the distribution of CD34^–Flk2^–, CD34⁺Flk2^–, and CD34⁺Flk2^–, which immunophenotypically correspond to LT-HSCs, ST-HSCs, and MPPs in the LSK population, from control and Gsk3-rnai secondary recipients. Percent cells are shown for the indicated gates. (E) Colony formation assay with sorted GFP⁺ cells from control and Gsk3-rnai secondary recipient BM was performed and scored as in Figure 1 using GFP⁺ BM from 5 control and 5 Gsk3-rnai mice. (F) The frequencies of common myeloid progenitor (CMP), granulocyte-monocyte progenitor (GMP), and megakaryocyte-erythroid progenitor (MEP) cells were measured by detection of CD16/32 and CD34 expression in the lineage^–sca-1^–c-kit⁺ gated population. The common lymphoid progenitor (CLP) fraction was measured as CD127⁺ cells in the lineage^–sca-1^loc-kit^lo gate. (G) Lethally irradiated mice were reconstituted with 4 × 10⁵ sorted GFP⁺ BM cells from secondary recipients of vector or Gsk3-rnai transduced BM. The Kaplan-Meier survival curve shows the survival of tertiary recipients of BM from control or Gsk3-rnai mice. (H) Absolute number of immunophenotypic HSCs/HPCs, as LSK cells, in control and Gsk3-rnai tertiary recipients. *P < 0.05.